CytOSorb TreatMent Of Critically Ill PatientS Registry

Inclusion Criteria:

1. Planned OR actual CytoSorb® 300 mL device utilization

2. Informed consent for prospective registry participation

Exclusion Criteria:

1. Use of the CytoSorb® 300 mL device for antithrombotic removal only

2. Intraoperative use of CytoSorb® 300 mL device during cardiac surgery only

3. The occurrence of a complication or other medically justified circumstance thatarises after written informed consent has been obtained from the patient and beforeor during the planned therapy and as a result of which the use of CytoSorb® 300 mLAdsorber is contraindicated or no longer appropriate.